Outbreaks of disease are becoming increasingly prevalent and devastating. The UN currently considers disease outbreaks to be foremost on their list of potential...
Emergex is a company aiming to produce revolutionary vaccines by taking advantage of advances in the fields immunogenics and nanotechnology. Using a library of immunogenic responses obtained via a novel mass spectrometry analytic technique, which are delivered via a nanoparticle system, Emergex hopes to prepare the world for future disease outbreaks.














